Geobacter sulfurreducens Armed with Biosynthetic Gold Nanoparticles for Tumor-Selective Cascade Catalytic Cancer Therapy
Nano Letters · 2026
DOI: 10.1021/acs.nanolett.5c05084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano Letters, 2026. Verfasst von Lingqing Zong und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Engineering, University of New South Wales, Sydney, New South Wales 2052, Australia. Hauptthemen laut MEDLINE: Gold, Metal Nanoparticles, Geobacter, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Medical Research Council of Australia, National Health and Medical Research Council, University of New South Wales.
Abstract (Originalsprache)
Catalytic nanomedicine represents an attractive therapeutic approach for cancer therapy while heavily relying on the catalytic activity and tumor selectivity of the catalyst. Here, a novel catalytic biohybrid ("bacterobot") of gold nanoparticle-coated electroactive bacterium is developed for enhanced catalytic cancer therapy. The electroactive G. sulfurreducens, for the first time used in cancer therapy, turbocharges the multienzyme-like catalytic activities of biosynthetic gold nanoparticles via cascade catalytic reactions to produce abundant reactive oxygen species to induce apoptosis and pyroptosis of tumor cells. Distinctive tumor accumulation and a tumor inhibition rate of 68% were achieved with single-dose intravenous injection of biohybrids in 4T1 tumor-bearing mice. Overall, the bacterobot biohybrid therapy demonstrates a high degree of therapeutic selectivity to tumor tissues and consequent excellent therapeutic efficacy and systemic biosafety, signifying the potential to create a paradigm shift in the way cancers are treated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemical Engineering, University of New South Wales, Sydney, New South Wales 2052, Australia.
- Australian Centre for NanoMedicine, University of New South Wales, Sydney, New South Wales 2052, Australia.
- School of Biomedical Engineering, University of New South Wales, Sydney, New South Wales 2052, Australia.
- Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, United States.
- School of Biomedical Engineering, University of Technology Sydney, Sydney, New South Wales 2007, Australia.
- Australian Institute for Microbiology and Infection, University of Technology Sydney, Ultimo, NSW 2007, Australia.
ORCID-Profile: Wei Deng, Cindy Gunawan, Rose Amal, Dewei Chu, Wei Tao, Zi Gu
Förderung
- Medical Research Council of Australia
- National Health and Medical Research Council
- University of New South Wales
Zitieren
APA
Zong, L., Sang, R., Zhang, X., Lim, J. L., Zhao, S., Deng, W., Gunawan, C., Amal, R., Yun, J., Chu, D., Tao, W., & Gu, Z. (2026). Geobacter sulfurreducens Armed with Biosynthetic Gold Nanoparticles for Tumor-Selective Cascade Catalytic Cancer Therapy. Nano Letters. https://doi.org/10.1021/acs.nanolett.5c05084
Vancouver
Zong L, Sang R, Zhang X, Lim JL, Zhao S, Deng W, et al. Geobacter sulfurreducens Armed with Biosynthetic Gold Nanoparticles for Tumor-Selective Cascade Catalytic Cancer Therapy. Nano Letters. 2026. doi:10.1021/acs.nanolett.5c05084
BibTeX
@article{Zong2026,
author = {Zong, Lingqing and Sang, Rui and Zhang, Xiuwen and Lim, Jie Lay and Zhao, Senfeng and Deng, Wei and Gunawan, Cindy and Amal, Rose and Yun, Jimmy and Chu, Dewei and Tao, Wei and Gu, Zi},
title = {Geobacter sulfurreducens Armed with Biosynthetic Gold Nanoparticles for Tumor-Selective Cascade Catalytic Cancer Therapy},
journal = {Nano Letters},
year = {2026},
doi = {10.1021/acs.nanolett.5c05084}
}
EUVIMED